Towards Healthcare
Peptide Therapeutics Market to Lead USD 81.5 Bn by 2034

Peptide Therapeutics Market Future Driven by Oncology Demand

According to market projections, the peptide therapeutics sector is expected to grow from USD 49.17 billion in 2024 to USD 81.5 billion by 2034, reflecting a CAGR of 5.35%. The peptide therapeutics market is growing due to rising demand for personalized medicine. North America is leading the market due to the rising number of clinical trials.

  • Insight Code: 6244
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The peptide therapeutics market stands at USD 51.81 billion in 2025 and is expected to reach USD 81.5 billion by 2034, growing at a CAGR of 5.35% from 2024 to 2034.

North America is currently leading the peptide therapeutics market share by 40% due to rising collaboration among the key players.

The peptide therapeutics market includes six segments such as by type, by route of administration, by application/therapeutic area, by synthesis technology, by distribution channel, and by region.

Key trends include rising cases of cancer and rare diseases.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.